Invivyd (IVVD) Operating Expenses (2021 - 2025)

Invivyd (IVVD) has 5 years of Operating Expenses data on file, last reported at $29.8 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses fell 9.95% year-over-year to $29.8 million; the trailing twelve-month figure through Dec 2025 stood at $109.0 million (down 46.12% YoY), and the FY2025 full-year result was $109.0 million, down 46.12% from the prior year.
• Operating Expenses for Q4 2025 stood at $29.8 million, up from $24.2 million in the prior quarter.
• Across five years, Operating Expenses topped out at $100.7 million in Q1 2022 and bottomed at $24.2 million in Q3 2025.
• The 5-year median for Operating Expenses is $46.7 million (2022), against an average of $49.9 million.
• The widest annual swing landed in 2022, when Operating Expenses soared 160.25%; it then plunged 66.27% in 2025.
• A 5-year view of Operating Expenses shows it stood at $83.1 million in 2021, then tumbled by 41.98% to $48.2 million in 2022, then soared by 59.2% to $76.8 million in 2023, then tumbled by 56.94% to $33.0 million in 2024, then declined by 9.95% to $29.8 million in 2025.
• The last three Operating Expenses figures came in at $29.8 million (Q4 2025), $24.2 million (Q3 2025), and $26.8 million (Q2 2025), per Business Quant data.

Peer Comparison